Low-level exposure to arsenic in drinking water and risk of type 2 diabetes: a systematic review and meta-analysis
European Journal of Epidemiology · 2026
DOI: 10.1007/s10654-026-01365-7 ↗Kurz gefasst
Metaanalyse in der Zeitschrift European Journal of Epidemiology, 2026. Verfasst von Paolo Boffetta und 2 weiteren Autor:innen. Beteiligte Einrichtung: Stony Brook Cancer Center, Stony Brook University, Lauterbur Dr, Stony Brook, NY, 11974, USA. paolo.boffetta@stonybrookmedicine.edu. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Drinking Water, Arsenic, Environmental Exposure. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Arsenic Science Task Force.
Themen: Diabetes mellitus
Abstract (Originalsprache)
The association between diabetes and low-level arsenic exposure in drinking water has not been adequately investigated. We conducted a two-stage meta-analysis of dose-response relationships from studies reporting incidence or prevalence of diabetes with average exposure up to 150 µg/L arsenic in drinking water. We conducted a literature search and included cross-sectional, case control and cohort studies and we extracted results for exposure to arsenic up to average concentration of 150 µg/L water. Prevalence and incidence were generically referred to as risk. We conducted study-specific linear regression to estimate the relative risk (RR) of diabetes for a 10 µg/L increase of arsenic, and combined the study-specific results in a random-effect meta-analysis. We addressed publication bias by excluding studies with the largest standard error; and identified a subset of high-quality studies. We also performed a one-stage meta-regression. We selected 11 studies including 12 populations from seven countries. The meta-analysis of their results yielded a relative risk (RR) of type 2 diabetes for a 10 µg/L arsenic increase within the range 0-150 µg/L equal to 1.07 (95% confidence interval [CI] 1.02-1.21, p heterogeneity = 0.006). There was evidence of publication bias (p = 0.004); after accounting for publication bias, the summary RR was 1.02 (95% CI 0.99-1.06, eight studies). The RR based on the high-quality studies was 1.03 (95% CI 0.97-1.09, five studies). The corresponding RR of the meta-regression was 1.007 (95% CI 0.998-1.017, 32 risk estimates). Accounting for publication bias and study quality, and considering heterogeneity of risk estimates, our two-stage meta-analysis supports a null association between low levels of arsenic in drinking water and type 2 diabetes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Stony Brook Cancer Center, Stony Brook University, Lauterbur Dr, Stony Brook, NY, 11974, USA. paolo.boffetta@stonybrookmedicine.edu.
- Department of Family, Population and Preventive Medicine, Renaissance School of Medicine, Stony Brook University, Stony Brook, NY, USA. paolo.boffetta@stonybrookmedicine.edu.
- Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy. paolo.boffetta@stonybrookmedicine.edu.
- Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy.
- Emory Global Diabetes Research Center, Woodruff Health Sciences Center, Emory University, Atlanta, GA, USA.
- Rollins School of Public Health, Emory University, Atlanta, GA, USA.
Förderung
- Arsenic Science Task Force
Zitieren
APA
Boffetta, P., Collatuzzo, G., & Narayan, K. M. V. (2026). Low-level exposure to arsenic in drinking water and risk of type 2 diabetes: a systematic review and meta-analysis. European Journal of Epidemiology. https://doi.org/10.1007/s10654-026-01365-7
Vancouver
Boffetta P, Collatuzzo G, Narayan KMV. Low-level exposure to arsenic in drinking water and risk of type 2 diabetes: a systematic review and meta-analysis. European Journal of Epidemiology. 2026. doi:10.1007/s10654-026-01365-7
BibTeX
@article{Boffetta2026,
author = {Boffetta, Paolo and Collatuzzo, Giulia and Narayan, K M Venkat},
title = {Low-level exposure to arsenic in drinking water and risk of type 2 diabetes: a systematic review and meta-analysis},
journal = {European Journal of Epidemiology},
year = {2026},
doi = {10.1007/s10654-026-01365-7}
}
EUVIMED